Use of lacidipine for the treatment of arteriosclerosis

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/44 (2006.01)

Patent

CA 2103805

The use of (E)-4-[2-[3-(1,1-dimethylethoxy)-3-oxo-1-propenyl]phenyl]-1,4- dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid diethyl ester (lacidipine) for the treatment and/or prevention of arteriosclerosis.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of lacidipine for the treatment of arteriosclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of lacidipine for the treatment of arteriosclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of lacidipine for the treatment of arteriosclerosis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2063538

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.